Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
294.50 CHF | -1.11% |
|
+1.90% | +15.26% |
Feb. 13 | Roche Elecsys sFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(K) Clearance | CI |
Feb. 13 | Roche: the stock stands out after an upgrade by UBS | CF |
Consensus | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
CHF 309.12 | +4.97% | 20 | |||||||
$981.47 | +16.25% | 26 | |||||||
$168.64 | +8% | 21 | |||||||
DKK 813.17 | +45.86% | 24 | |||||||
$204.9 | +6.24% | 27 | |||||||
GBX 177.19 | +20.02% | 20 | |||||||
$116.38 | +40.2% | 24 | |||||||
CHF 113.48 | +6.84% | 21 | |||||||
$316.7 | +8.77% | 26 | |||||||
$31.18 | +22.11% | 22 | |||||||
€116.85 | +12.68% | 22 | |||||||
$104.77 | +0.67% | 27 | |||||||
$61.24 | +13.62% | 21 | |||||||
¥7,510 | +3.57% | 15 | |||||||
GBX 17.89 | +24.68% | 20 | |||||||
¥6,216.67 | +70.51% | 18 | |||||||
GBX 3.993 | +3.9% | 17 | |||||||
¥4,823.82 | +16.21% | 17 | |||||||
CN¥59.81 | +31.44% | 16 | |||||||
Average | 1,165.65 | +18.76% | 21 | ||||||
Weighted average by Cap. | 670.09 | +17.26% | 23 |
- Stock Market
- Equities
- ROG Stock
- Sector Roche Holding AG
- Sector consensus